EP 1858872 A1 20071128 - DERIVATIVES OF N-[(4,5-DIPHENYL-2-THIENYL) METHYL] AMINE (AMIDE, THIOUREA AND UREA) AS CANNABINOID CB1 RECEPTOR ANTAGONISTS
Title (en)
DERIVATIVES OF N-[(4,5-DIPHENYL-2-THIENYL) METHYL] AMINE (AMIDE, THIOUREA AND UREA) AS CANNABINOID CB1 RECEPTOR ANTAGONISTS
Title (de)
DERIVATE VON N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMIN (AMID, THIOHARNSTOFF UND HARNSTOFF) ALS CANNABINOID-CB1-REZEPTORANTAGONISTEN
Title (fr)
DÉRIVÉS DE N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE (AMIDE, THIOURÉE ET URÉE) COMME ANTAGONISTES DES RÉCEPTEURS CB1 DES CANNABINOÏDES
Publication
Application
Priority
- FR 2006000219 W 20060201
- FR 0501366 A 20050209
Abstract (en)
[origin: WO2006084975A1] The invention relates to compounds of formula (I) wherein X represents a group of formula (II); and R3 and R4 independently represent a non-substituted, monosubstituted, disubstituted, or trisubstituted phenyl. The invention also relates to a method for the preparation and application of said compounds as cannabinoid CB1 receptor antagonists.
IPC 8 full level
C07D 333/20 (2006.01); A61K 31/381 (2006.01); A61P 1/00 (2006.01); A61P 3/04 (2006.01); A61P 25/18 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01)
CPC (source: EP KR US)
A61K 31/381 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/00 (2017.12 - EP); A61P 7/04 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/02 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 25/32 (2017.12 - EP); A61P 25/34 (2017.12 - EP); A61P 25/36 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 333/20 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2006084975A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
FR 2881744 A1 20060811; FR 2881744 B1 20070427; AR 052898 A1 20070411; AU 2006212162 A1 20060817; BR PI0606942 A2 20090728; CA 2596613 A1 20060817; CN 101128451 A 20080220; EP 1858872 A1 20071128; IL 185035 A0 20071203; JP 2008530060 A 20080807; JP 4823236 B2 20111124; KR 20070115941 A 20071206; MX 2007009439 A 20080306; RU 2007133602 A 20090320; TW 200639160 A 20061116; US 2008009543 A1 20080110; US 2010137402 A1 20100603; US 7687537 B2 20100330; UY 29366 A1 20061002; WO 2006084975 A1 20060817
DOCDB simple family (application)
FR 0501366 A 20050209; AR P060100424 A 20060207; AU 2006212162 A 20060201; BR PI0606942 A 20060201; CA 2596613 A 20060201; CN 200680004418 A 20060201; EP 06709212 A 20060201; FR 2006000219 W 20060201; IL 18503507 A 20070802; JP 2007554591 A 20060201; KR 20077020475 A 20070907; MX 2007009439 A 20060201; RU 2007133602 A 20060201; TW 95104263 A 20060208; US 70188710 A 20100208; US 83216207 A 20070801; UY 29366 A 20060208